Mayer, L., Pandak, W. M., Melmed, G. Y., Hanauer, S. B., Johnson, K., Payne, D., . . . Fischkoff, S. A. (2013). Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study. Inflammatory bowel diseases, 19(4), 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df
Citace podle Chicago (17th ed.)Mayer, Lloyd, William M. Pandak, Gil Y. Melmed, Stephen B. Hanauer, Kristine Johnson, Denise Payne, Herbert Faleck, Robert J. Hariri, a Steven A. Fischkoff. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases 19, no. 4 (2013): 754-760. https://doi.org/10.1097/MIB.0b013e31827f27df.
Citace podle MLA (9th ed.)Mayer, Lloyd, et al. "Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease: A Phase 1 Study." Inflammatory Bowel Diseases, vol. 19, no. 4, 2013, pp. 754-760, https://doi.org/10.1097/MIB.0b013e31827f27df.